Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BAFNAPH Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Low ROE but improving trend
Low operating margin but improving trend
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0931997.
Snapshot
See detailed analysis
BAFNAPH Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BAFNAPH Bulk, Block & Insider Trades
BAFNAPH Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Others
Capital Reduction (CRD)The number of equity shares existing as on record date shall be reduced by 10 percentage. Ex-date: 26th Aug 2019 Announced on: 15th Aug 2019
Company Profile
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.
Key personnel
Ms. Shanmugam HemalathaD
Executive Chairman of the Board, Whole Time Director
Mr. Mahaveer Chand Bafna
Chief Executive Officer
Mr. Melagiri Sridhar
Chief Financial Officer
Mr. A. Mohanachandran
Chief Compliance Officer, Company Secretary
Mrs. Akilapriya Chintalapati RajuD
Non-Executive Non Independent Director
Mr. Upendar Mekala ReddyD
Non-Executive Non-Independent Director
Mrs. Ravichandran ChitraD
Non-Executive Independent Director
Mr. Navin KumarD
Additional Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Bafna Pharmaceuticals Ltd.?
The current share price of Bafna Pharmaceuticals Ltd. is ₹ 138.91 as of 09 Jan 2026.
What is the PE ratio of Bafna Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Bafna Pharmaceuticals Ltd. is 39.76 as of the latest financial data.
What is the ROE and ROCE of Bafna Pharmaceuticals Ltd.?
Bafna Pharmaceuticals Ltd. has a Return on Equity (ROE) of 9.50% and a Return on Capital Employed (ROCE) of 9.93% as per the latest financial reports.
What is the market cap of Bafna Pharmaceuticals Ltd.?
The market capitalization of Bafna Pharmaceuticals Ltd. stands at ₹ 328.61 Cr.
What is the dividend yield of Bafna Pharmaceuticals Ltd.?
The dividend yield of Bafna Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Bafna Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Bafna Pharmaceuticals Ltd. is 37.24.
What is the FII and DII holding in Bafna Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 9.34% and Domestic Institutional Investors (DII) hold 0.00% of Bafna Pharmaceuticals Ltd. shares.
What sector does Bafna Pharmaceuticals Ltd. belong to?
Bafna Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Bafna Pharmaceuticals Ltd. stock?
The beta of Bafna Pharmaceuticals Ltd. stock is 0.58, indicating its volatility relative to the broader market.
